LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 332 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.08 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $348,000 | -13.0% | 3,500 | 0.0% | 0.01% | -7.7% |
| Q2 2019 | $400,000 | +0.5% | 3,500 | +10.6% | 0.01% | -7.1% |
| Q1 2019 | $398,000 | -7.2% | 3,164 | 0.0% | 0.01% | -17.6% |
| Q4 2018 | $429,000 | -50.6% | 3,164 | 0.0% | 0.02% | -41.4% |
| Q3 2018 | $869,000 | +36.2% | 3,164 | +2.7% | 0.03% | +31.8% |
| Q2 2018 | $638,000 | +25.3% | 3,080 | 0.0% | 0.02% | +22.2% |
| Q1 2018 | $509,000 | +20.6% | 3,080 | 0.0% | 0.02% | +20.0% |
| Q4 2017 | $422,000 | +28.7% | 3,080 | +27.9% | 0.02% | +25.0% |
| Q3 2017 | $328,000 | +39.6% | 2,408 | +24.6% | 0.01% | +33.3% |
| Q2 2017 | $235,000 | +113.6% | 1,932 | +86.5% | 0.01% | +125.0% |
| Q1 2017 | $110,000 | +29.4% | 1,036 | +23.3% | 0.00% | 0.0% |
| Q4 2016 | $85,000 | – | 840 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |